10.6084/m9.figshare.7975223.v1 Xiaotong Li Xiaotong Li Sarah Warren Sarah Warren Vasiliki Pelekanou Vasiliki Pelekanou Vikram Wali Vikram Wali Alessandra Cesano Alessandra Cesano Mingdong Liu Mingdong Liu Patrick Danaher Patrick Danaher Nathane Elliott Nathane Elliott Zeina Nahleh Zeina Nahleh Daniel Hayes Daniel Hayes Gabriel Hortobagyi Gabriel Hortobagyi William Barlow William Barlow Christos Hatzis Christos Hatzis Lajos Pusztai Lajos Pusztai Additional file 4: of Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial Springer Nature 2019 Tumor infiltrating lymphocytes PD-L1 Immune-related genes Neoadjuvant treatment Bevacizumab 2019-04-10 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_of_Immune_profiling_of_pre-_and_post-treatment_breast_cancer_tissues_from_the_SWOG_S0800_neoadjuvant_trial/7975223 Figure S4. Correlation between TIL counts and PD-L1 expression. A. Correlation between TIL counts and PD-L1 expression on tumor cells. B. Correlation between TIL counts and PD-L1 expression on stromal cells. C. TIL counts in cases with positive and negative PD-L1 expression on tumor cells. D. TIL counts in cases with positive and negative PD-L1 expression on stromal cells. For A and B, Solid line and grey shade represent linear regression line and 95% confidence interval, respectively. Besides, Pearson correlation coefficient r and p-value are added. For C and D, p values are from Wilcoxon test. (PDF 74 kb)